Skip to main content
NIH funding notice PA-19-081

Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)

Closed on January 7, 2022.

Posted
November 26, 2018
Close date
January 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $507,981 in first-year total cost, median $253,991.

Most frequent study sections

  1. Instrumentation and Systems Development Study Section[ISD]1
  2. Special Emphasis Panel[ZRG1 IDIB-G (90)]1

Most frequent institutions

  1. RENSSELAER POLYTECHNIC INSTITUTE1
  2. UNIVERSITY OF COLORADO1
Competing awards under PA-19-081 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Acoustofluidic Pipette for Rapid Serodiagnosis of Candida Infection1R21AI154266-01A1SHIELDS IV, CHARLES WYATTUNIVERSITY OF COLORADO, CO$254,793ISD
2021Glycomics-driven diagnostics for Candida auris1R21AI156573-01A1CHATURVEDI, VISHNULINHARDT, ROBERT JRENSSELAER POLYTECHNIC INSTITUTE, NY$253,188ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.